Jonathan Young - Chief Operating Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
AKRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Young - trading volume in the past year for Akero Therapeutics, Inc.

Holdings reported by Jonathan Young for Akero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 201K $9M $44.88 Mar 12, 2025 Direct
Common Stoek 263K $6.59M $25.03 Apr 1, 2024 Direct
Common Stock 20K $898K $44.88 Mar 12, 2025 By CM Irrevocable Trust
Common Stock 20K $898K $44.88 Mar 12, 2025 By EA Irrevocable Trust
Common Stock 20K $898K $44.88 Mar 12, 2025 By JL Irrevocable Trust
Stock Option (Right to Buy) 0 Jan 23, 2025 Direct Common Stock

Transactions reported by Jonathan Young for Akero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.